The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib trial of enzalutamide (Enza) with venetoclax (Ven) in metastatic castration-resistant prostate cancer (mCRPC).
 
Stuthi Perimbeti
No Relationships to Disclose
 
Anmbreen Jamroze
No Relationships to Disclose
 
Kristopher Attwood
No Relationships to Disclose
 
Bailey Farmer
No Relationships to Disclose
 
Jan Hendrik Beumer
Employment - Voisin Consulting (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Genentech
Research Funding - Abbvie (Inst); TriSalus Life Sciences (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)
Expert Testimony - Astellas Pharma; AstraZeneca/Merck; Pfizer; Spectrum Pharmaceuticals; Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Applied Isotope Technologies; Qrono
 
Robert Bies
No Relationships to Disclose
 
Ellis Glenn Levine
Research Funding - Oncolytics (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Jason Kirk
No Relationships to Disclose
 
Dean Tang
No Relationships to Disclose
 
Gurkamal S. Chatta
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Dharmesh Gopalakrishnan
No Relationships to Disclose